Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

NCT00834262

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Kfar Saba, Israel

View Trial Details

Completed

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

NCT00699179

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations: Novo Nordisk Investigational Site Belgrade, Serbia and Montenegro

View Trial Details

Completed

Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes

NCT01565733

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Warsaw, Poland

View Trial Details

Completed

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

NCT00700765

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations: Novo Nordisk Investigational Site Jakarta, Indonesia

View Trial Details

Completed

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

NCT00675220

Conditions: Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
Locations: Novo Nordisk Investigational Site Manila, Philippines

View Trial Details

Completed

An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice

NCT01498900

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

NCT00698126

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Rome, Italy

View Trial Details

Completed

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

NCT00771680

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Moscow, Russia

Novo Nordisk Investigational Site Kiev, Ukraine

View Trial Details

Completed

Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus

NCT00687284

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Košice, Slovakia

View Trial Details

Completed

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

NCT00655044

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations: Novo Nordisk Investigational Site Moscow, Russia

View Trial Details